Eli Lilly, MiNA Therapeutics To Collaborate On Research Using MiNA's SaRNA Technology - Quick Facts

(RTTNews) - Eli Lilly and Co. (LLY) and MiNA Therapeutics Ltd., a pioneer in RNA activation therapeutics, announced Tuesday a global research collaboration to develop novel drug candidates using MiNA's proprietary small activating RNA (saRNA) technology platform. This new technology will expand the breadth of Lilly's RNA therapeutics platform. Under...